Description
Salazopyrin-EN-TABS (Sulfasalazine) Coated Tablets 500 mg. №100
Ingredients
- Active ingredient: Each tablet contains 500 mg of sulfasalazine.
- Other inactive ingredients include cellulose, magnesium stearate, and colloidal silicon dioxide.
Dosage
Dosage: The usual adult dose is 2 to 3 tablets daily, taken in divided doses. Dosage may vary depending on the condition being treated.
Indications
Indications: Salazopyrin-EN-TABS are indicated for the treatment of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. It works by reducing inflammation in the colon.
Contraindications
Contraindications: Do not use if allergic to sulfasalazine or any inactive ingredients. Contraindicated in patients with intestinal or urinary obstruction.
Directions
Directions: Swallow the tablets whole with a full glass of water. Do not crush or chew. Take as directed by your healthcare provider.
Scientific Evidence
Salazopyrin-EN-TABS have been studied for efficacy in treating inflammatory bowel diseases. Research in the Journal of Gastroenterology and Hepatology showed sulfasalazine’s effectiveness in inducing and maintaining remission in ulcerative colitis patients.
Additional Information
- Monitor for side effects like nausea, headache, and rash.
- Regular blood tests may be needed to check for adverse effects on the liver or blood cells.
Pharmacological Effects: Sulfasalazine reduces colon inflammation by inhibiting the production of inflammatory chemicals, alleviating symptoms of inflammatory bowel diseases.
Clinical Trials: A study in the American Journal of Gastroenterology compared sulfasalazine with other treatments for Crohn’s disease, finding it effective in reducing disease activity and improving patient quality of life.
